Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Belzutifan by Merck & Co. is for the treatment of renal cell carcinoma, central nervous system hemangioblastomas, and pancreatic neuroendocrine tumors.
Gefapixant will reduce cough frequency, thereby improving patients’ quality of life.
Daridorexant will help treat insomnia.
An oral antiviral drug by Merck & Co. has joined the armamentarium of the pharmacological fight against COVID-19.
Molnupiravir pills by Merck & Co. can help COVID-19 patients avoid going to the hospital or dying.
Maribavir will suppress cytomegalovirus when ganciclovir, valganciclovir, cidofovir, or foscarnet do not work.